Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52,816 Patients From 12 Randomized Trials
2020
Background: New randomized controlled trials (RCTs) have become available on oral P2Y12 inhibitors in acute coronary syndrome (ACS). We aimed to evaluate current evidence comparing the efficacy and...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
26
References
35
Citations
NaN
KQI